In Other News

• Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk

• 150 Million Rapid COVID-19 Tests from Abbott Begin Rolling out Across US

• FDA Grants First Ever EUA to COVID-19 POC Antibody Test for Use with Fingerstick Blood Samples

• 120 Million COVID-19 Rapid Tests to Be Made Available for Low and Middle Income Countries

• Some COVID-19 Vaccines Could Work Better on One Patient Population than Others, Says Dr. Anthony Fauci

• China Doses Thousands with Unproven COVID-19 Vaccines Having Potentially Harmful Side Effects

• COVID-19 Saliva Tests Could Detect Silent Carriers

• Hologic Granted FDA Emergency Use Authorization for Asymptomatic COVID-19 Testing with Panther Fusion SARS-CoV-2 Assay

• New Preventative Nasal Spray Reduces Viral Replication by Up to 96% in COVID-19 Challenge Study

• SARS-CoV-2 Viral Load Could Be Key to Recovery from COVID-19

• COVID-19 Patients Having Sufficient Vitamin D Experience Reduced Complications and Lower Mortality

• SARS-CoV-2 Mutations Having Higher Transmission Rates Could Require Yearly COVID-19 Vaccine Shots

• Johnson & Johnson COVID-19 Vaccine Generates Strong Immune Response in Mid-Stage Trials

• Dried Blood Spot Sampling Offers Inexpensive Way to Widen Access to COVID-19 Antibody Testing

• Blood-Based Test That Accurately Identifies Viral Infection Before Symptoms Develop Could Help in Early Identification of SARS-CoV-2

• New, Portable COVID-19 Saliva-Based Testing Device to Deliver Results in as Little as 20 Minutes

• Cepheid Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV Granted FDA Emergency Use Authorization

• Man's Best Friend: The Ultimate COVID-19 Screening Solution?

• FDA Authorizes First Nanopore Sequencing-Based Test for SARS-CoV-2

• Statins Reduce COVID-19 Severity by Removing Cholesterol Used by SARS-CoV-2 to Infect Cells

• Researchers Predict Which Antibodies Provide Best Protection Against SARS-CoV-2 and Which COVID-19 Vaccines Might Help

• Discovery of Highly Effective SARS-CoV-2 Antibodies to Aid Development of Passive Vaccination

• New ABC Test for Influenza A, Influenza B, and COVID-19 to Be Launched in First Week of October